Cervical Screening with the ThinPrep® Pap test
NEWS: Liquid Based Cytology (LBC), such as the ThinPrep Pap test, is now listed on the Medicare Benefits Scheme (MBS) – Item 73069. This is an interim arrangement by the Department of Health until the renewed National Cervical Screening Program is implemented.
From 1 May - 30 November 2017:
LBC will be added to the MBS. For each patient a Medicare rebate will only be payable for one cervical screening test for cytology, either the LBC test or the conventional cytology test. If you choose to do both tests, you will need to inform patients that they will incur an out-of-pocket cost.
The LBC test will be set at a Medicare fee of $36.00 per test and will exist alongside the rebate for the conventional cytology test.
Please refer to the Department of Health’s letter here for the full details.